Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Smartlands is a blockchain-based digital finance and investment ecosystem. It allows asset owners to turn an ownership right to a share of any asset, into a tradable digital token attributing it almost unlimited liquidity. In the UK, Smartlands is the first platform for crowdfunding investments that allows investors to use digital currencies alongside fiat currencies to raise capital. The platform boasts of a 16,000 strong community following with over 11,000 wallets opened since its inception. It has a reputed list of partners including Colliers International, CMS, Archax, UK Sotheby’s, and many more. They have been awarded the 'Best Crowdfunding Platform' at the 2020 FinTech Breakthrough Awards and have been featured in Yahoo Finance, Forbes, Coindesk, Benzinga, and Investors Chronicle to name a few. With the investment, the company will grow its internal engineering team and obtain the necessary licenses to move its business forward across Europe.
days to go:
Expired
investment:
£379,183
Widewalls is an online platform where art lovers discover and collect modern and contemporary art. In a nutshell, this platform connects art collectors and art dealers. Widewalls presents 3000 art venues, 12,000 artist profiles, and 19,000 articles covering modern and Contemporary art. This platform displays 20,000 artworks to discover and auctions results covering approximately 80% of the market over the past 4 years. In total, more than 120,000 pages on Widewalls are indexed by Google. It is the media partner of 48 international art fairs. The company's mission is to help traditional galleries and auction houses access and serve the online market more efficiently.
days to go:
Expired
investment:
£235,490
Clim8 is a financial technology company that aims to move billions of pounds of investment into sectors such as clean energy, clean technology, sustainable food, smart mobility, and recycling. It is authorised by the Financial Conduct Authority (FCA). The company quotes United Nations data arguing that the world needs to invest $2.4 trillion every year into clean energy, from now until 2035, to meet climate change targets. Clim8 aims to capitalise on this objective through its app. The company has raised £1.9 million in seed funding across two rounds, in December 2019 and April 2020, respectively. It also overachieved its first Crowdcube campaign by over 300%. The company will use the investment to continue onboarding its waiting list of over 10,000 and grow its business across different verticals.
days to go:
Expired
investment:
£2,348,974
Creative Minds is a community of artists giving therapeutic art sessions to care homes. They currently have 30 artist licensees delivering 350 art sessions to over 1500 people per month. The investment will be used to open new revenue streams and establish a global franchise presents in countries such as US, Australia and Canada.
days to go:
Expired
investment:
£30,420
Husky is the UK’s only open, SaaS platform for workplace pensions. For employers, the platform deals with legal and compliance burdens of auto-enrolment while helping reduce pension costs. For individuals and company directors, the app is instrumental in bringing profitable and responsible investments with the Husky for Everyone app. And for advisers and accountants, it ensures strong client relationships amidst transparency and efficiency. Close to 1.4 million employers & 22.6 million workers are affected by the UK’s automatic enrolment (AE) legislation. Within this market, a conservative estimate of fees charged on employees by pension providers is £2 billion a year; Husky aims to disrupt this market & is ready to scale. Its method of operation has led to it achieving important milestones. With more than 1000 firms onboarded, a 92% renewal rate, and an average annual fee of £438, Husky charges its onboarded firms (including Crowdcube) with monthly recurring fees laid out as part of a 3-year subscription model. With the funds received, the company aims to disrupt the relatively stagnant workplace pensions industry with innovative products and empower its customers.
days to go:
Expired
investment:
£417,338
